COMPARISON OF THE EFFECTS OF PARICALCITOL AND CALCITRIOL TREATMENTS ON OSTEOPROTEGERIN (OPG) LEVELS IN HEMODIALYSIS PATIENTS

ORUÇ A., YILDIZ A., Gul C. B., Aktas N., Bal O., Korkmaz S., ...More

ACTA MEDICA MEDITERRANEA, vol.32, no.2, pp.325-329, 2016 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.19193/0393-6384_2016_2_48
  • Journal Name: ACTA MEDICA MEDITERRANEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.325-329
  • Bursa Uludag University Affiliated: Yes

Abstract

Introduction: Osteoprotegerin (OPG), a natural glycoprotein, which plays important roles on regulation and development of vascular calcification, is a key regulator molecule in bone turnover. Studies revealed different results about effects of vitamin D receptor activators (VDRAs) on OPG levels. This study investigated the changes in serum OPG levels and its relationships following VDRAs, paricalcitol and calcitriol treatments, in hemodialysis patients.